Cardiac Surgery

Cardiothoracic surgery includes coronary artery bypass surgery (CABG), heart valve repair or replacement, left ventricular assist device (LVAD) placement, heart transplant, assisting in minimally invasive transcatheter valve structural heart procedures such as TAVR, left atrial appendage (LAA) occlusion, septal myectomy, surgical ablation for arrhythmias, and reconstruction of the heart in congenial heart disease cases. 

Vascudyne's off-the-shelf conduit for CABG surgeries

New off-the-shelf conduit for CABG shows promise in first-in-human study

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.

corcym Perceval Plus LANCELOT

FDA-approved surgical aortic valve implanted for first time in US

The next-generation valve from Corcym features a sutureless frame as well as laser-cut leaflets and thread holes.

Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization

Ethylene oxide is an odorless gas used to sterilize pacemakers, leads, stents and many other medical devices. Long-term exposure, however, can cause cancer. The Biden administration made it a priority to reduce ethylene oxide emissions, but many critics thought those cuts were too extreme.  

surgeon who uses AI

Nearly half of all surgeons have considered leaving the profession due to burnout

Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic. 

heart surgery surgeons

AATS wants to improve research in the field of cardiothoracic surgery

The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

AI helps identify risk in adults with congenital heart disease

STS plans on using new research out of Mayo Clinic to help with the development of a surgical risk calculator for adults with this challenging condition.

BioVentrix's Revivent system

Heart failure company BioVentrix files for IPO

The company, known for its advanced heart failure technologies, hopes to be traded on the Nasdaq under the symbol BVXX.

progress step forward business announce

New heart catheter for cell therapy delivery 1 step closer to FDA approval

The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue.